REPLIGEN CORP Insider Trading for May 2020

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in REPLIGEN CORP.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in REPLIGEN CORP for May 2020.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 26 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	M	32.40	3,086	99,986	50,154
May 26 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	M	24.98	39,037	975,144	0
May 26 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	M	16.55	7,916	131,010	1
May 26 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Buy	M	32.40	3,086	99,986	233,327	230.2 K to 233.3 K (+1.34 %)
May 26 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	141.58	100	14,158	230,241	230.3 K to 230.2 K (-0.04 %)
May 26 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	140.99	1,377	194,143	230,341	231.7 K to 230.3 K (-0.59 %)
May 26 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	140.04	28,980	4,058,359	231,718	260.7 K to 231.7 K (-11.12 %)
May 26 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	139.17	16,496	2,295,748	260,698	277.2 K to 260.7 K (-5.95 %)
May 26 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Buy	M	24.98	39,037	975,144	277,194	238.2 K to 277.2 K (+16.39 %)
May 26 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Buy	M	16.55	7,916	131,010	238,157	230.2 K to 238.2 K (+3.44 %)
May 26 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	M	67.71	2,109	142,800	0
May 26 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Sell	S	142.53	3,009	428,873	2,664	5.7 K to 2.7 K (-53.04 %)
May 26 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Buy	M	67.71	2,109	142,800	5,673	3.6 K to 5.7 K (+59.18 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	140.29	182	25,533	119,439	119.6 K to 119.4 K (-0.15 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	139.40	282	39,311	119,621	119.9 K to 119.6 K (-0.24 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	136.98	43	5,890	119,903	119.9 K to 119.9 K (-0.04 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	135.91	10	1,359	119,946	120 K to 119.9 K (-0.01 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	140.29	182	25,533	119,439	119.6 K to 119.4 K (-0.15 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	139.40	282	39,311	119,621	119.9 K to 119.6 K (-0.24 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	136.98	43	5,890	119,903	119.9 K to 119.9 K (-0.04 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	135.91	10	1,359	119,946	120 K to 119.9 K (-0.01 %)
May 19 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	140.69	435	61,200	26,089	26.5 K to 26.1 K (-1.64 %)
May 19 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	140.43	660	92,684	32,267	32.9 K to 32.3 K (-2.00 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	128.18	1,761	225,725	1,761
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	142.45	80	11,396	119,956	120 K to 120 K (-0.07 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	141.45	77	10,892	120,036	120.1 K to 120 K (-0.06 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	140.62	180	25,312	120,113	120.3 K to 120.1 K (-0.15 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	139.32	122	16,997	120,293	120.4 K to 120.3 K (-0.10 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	138.60	269	37,283	120,415	120.7 K to 120.4 K (-0.22 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	136.92	160	21,907	120,684	120.8 K to 120.7 K (-0.13 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	135.76	712	96,661	120,844	121.6 K to 120.8 K (-0.59 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	722	0	121,556	120.8 K to 121.6 K (+0.60 %)
May 19 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	A	128.18	1,285	164,711	1,285
May 19 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Grant	A	0.00	527	0	2,450	1.9 K to 2.5 K (+27.41 %)
May 19 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	A	128.18	1,285	164,711	1,285
May 19 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Grant	A	0.00	527	0	3,564	3 K to 3.6 K (+17.35 %)
May 19 2020	RGEN	REPLIGEN CORP	MUIR GLENN P	Director	Option Exercise	A	128.18	1,285	164,711	1,285
May 19 2020	RGEN	REPLIGEN CORP	MUIR GLENN P	Director	Grant	A	0.00	527	0	5,905	5.4 K to 5.9 K (+9.80 %)
May 15 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Option Exercise	M	32.40	9,024	292,378	3,086
May 15 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Option Exercise	M	26.05	3,170	82,579	0
May 15 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	132.37	846	111,985	32,927	33.8 K to 32.9 K (-2.50 %)
May 15 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	131.38	3,013	395,848	33,773	36.8 K to 33.8 K (-8.19 %)
May 15 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	130.20	1,700	221,340	36,786	38.5 K to 36.8 K (-4.42 %)
May 15 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	128.70	1,612	207,464	38,486	40.1 K to 38.5 K (-4.02 %)
May 15 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	127.75	2,865	366,004	40,098	43 K to 40.1 K (-6.67 %)
May 15 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	126.77	5,358	679,234	42,963	48.3 K to 43 K (-11.09 %)
May 15 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Buy	M	32.40	9,024	292,378	48,321	39.3 K to 48.3 K (+22.96 %)
May 15 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Buy	M	26.05	3,170	82,579	39,297	36.1 K to 39.3 K (+8.77 %)
May 15 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Option Exercise	M	33.87	2,000	67,740	10,850
May 15 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Option Exercise	M	33.05	6,000	198,300	4,000
May 15 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	128.55	95	12,212	26,524	26.6 K to 26.5 K (-0.36 %)
May 15 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	128.02	6,293	805,630	26,619	32.9 K to 26.6 K (-19.12 %)
May 15 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	126.88	1,612	204,531	32,912	34.5 K to 32.9 K (-4.67 %)
May 15 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Buy	M	33.87	2,000	67,740	34,524	32.5 K to 34.5 K (+6.15 %)
May 15 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Buy	M	33.05	6,000	198,300	32,524	26.5 K to 32.5 K (+22.62 %)